ArticleTheranostics2024

The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy.

Ying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.